Seeking Alpha

Penn Bioinvestor's  Instablog

I have extensive knowledge on drug discovery, also I am interested in fundamental analysis of biotech/pharma stocks. See Seeking Alpha's policy on anonymous authors: http://seekingalpha.com/article/69847-seeking-alpha-policy-on-anonymous-authorship
  • Biotech stocks are heavily manipulated now 1 comment
    Jul 16, 2009 07:22 PM | about stocks: BFRM, HGSI, ABIO, BDSI

    Today, four biotech stocks caught my eyes and their price action are totally un-justified.

    BDSI got their pain killer NDA approved, BFRM got their 501 cleared by  FDA. Both stocks shot up after the news, but then retreated back to the level as if there are no good news at all. Call this sell on news?

    On the other hand, HGSI and ABIO rallied without any news. Indead they are among the best performers of the day. IMHO, those two rallies totally are un-justified, more like a pump and dump game to me. HGSI key-Phase III is to be released monday morning pre-market, most analysts believe it will be a failure. ABIO drug is rejected by FDA last month and was asked to conduct more clinical trials to solve several issue. Yes, the cash is stll above the market capital, but unless the company liquidate itself and return asset back to investors, it still looks over-valued to me. Don't forget clinical trials are cash burning machine and all those money go away fast.

    What can I say? The market is irrational and stocks look heavily manipulated. The current market sentiment definately doesn't favor biotech sector. But eventually, the price of stocks will reflect their real value.

    Themes: biotechnology Stocks: BFRM, HGSI, ABIO, BDSI
Back To Penn Bioinvestor's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

This post has 1 comment:

  •  
    They definitely appear to be manipulated. It may be very possible that the hedge fund that recently got involved with BDSI may be a factor in this. It upsets me because I bought BDSI weeks ago in anticipation of this approval and the "landmark" event turned out to be a dud. At least for now.
    Jul 16 08:05 PM | Link | Reply
Full index of posts »
Latest Followers

StockTalks

  • Watch THRX. The FDA to decide on 11/26/09 for Vibativ HAP. Most likely a delay of approval, but opportunity to accumulate on dip.
    Nov 26, 2009
  • Buy XNPT around $16.
    Nov 11, 2009
  • ARNA: Rodman/Renshaw Cuts to Underperform from Market Perform; Target Price: $3.00
    Sep 18, 2009
More »
Posts by Ticker
ABIO, ARNA, ASTM, AVNR, BDSI, BFRM, BMY, DNDN, GERN, HGSI, LLY, MEDX, MRK, NVS, OPXA, OREX, PFE, SNY, SOMX, STEM, THRX, TSPT, TTNP.PK, VNDA, VVUS, XNPT

Latest Comments


Most Commented
  1. Vivus(VVUS) is in the driver's seat for obesity experiental drug (2 Comments)
  2. How to correctly understand the value of VVUS (2 Comments)
  3. Is VVUS secondary offering similar story to HGSI, DNDN? (2 Comments)
  4. Biotech stocks are heavily manipulated now (1 Comment)
  5. Expect VNDA buyout soon (1 Comment)
Posts by Themes
Biotechnology, biotechnology
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.